KDI’s statement losing rationale

Published: 2008-05-29 07:00:00

Updated: 2008-05-29 07:00:00

The recent Korea Development Institute’s statement that Korean generic medicines are more expensive than foreign counterparts came under fire from the domestic pharmaceutical industry.

The industry is casting a doubt to the KDI’s intention on local prices of generic drugs, saying the Korea gov...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK